Watch here tomorrow a new accredited, serialized tweetorial on optimizing the role of the #pharmacist in #cardiometabolic care. Earn 0.5 CE/#CME credits: #physicians, #nurses, #pharmacists! Expert faculty @johnfanikos. #medtwitter @academiccme #FOAMed @SnayCardsPharmD @couminator
— cardio-met (@cardiomet_CE) August 9, 2021
2) This series is supported by educational grants from AstraZeneca, Bayer, Chiesi, and NovoNordisk and is intended for healthcare providers. Faculty disclosures are listed at https://t.co/gvXca4G9Xm.
— cardio-met (@cardiomet_CE) August 10, 2021
4) . . . by multiple specialists. The burden falling solely on physicians sometimes thwarts guidelines-based care and can result in patient confusion, higher costs, and poorer outcomes. The #pharmacist plays a critical role in bridging the multiple gaps in current care.
— cardio-met (@cardiomet_CE) August 10, 2021
6) . . . shown remarkable efficacy and safety in improving outcomes in patients with #CVD in the presence of and, in the absence of #diabetes. These “#cardiometabolic” drugs blur interdisciplinary lines and perhaps call for a “referee” or “scorekeeper” . . .
— cardio-met (@cardiomet_CE) August 10, 2021
8) Closer collaboration and coordination of care maximizes the likelihood of achieving improved CV and T2D outcomes as these therapies are employed and risk reduction advice is given. We need to be better. Enter the pharmacist. pic.twitter.com/35r1c5xv5D
— cardio-met (@cardiomet_CE) August 10, 2021
10) . . . optimizing the pharmacologic treatment of disease-use of good medications and good medication taking practices while being vigilant for and avoiding adverse effects; and smoothing transitions of care (i.e., medication reconciliation) (https://t.co/XiyFbWw3Wz).
— cardio-met (@cardiomet_CE) August 10, 2021
12) So, a quiz. Data have shown that pharmacist interventions have been shown to consistently benefit the management of which of the following?
— cardio-met (@cardiomet_CE) August 10, 2021
14) Welcome back! I am @johnfanikos and we are back to discuss the optimal role of the #pharmacist in #cardiometabolic care. You have found the web’s ONLY source of accredited tweetorials in this space. Welcome #pharmacists, and also #physicians #nurses #PAs #NPs! pic.twitter.com/ArNUXlrLqj
— cardio-met (@cardiomet_CE) August 11, 2021
16) The use of guidelines-driven care in cardiometabolic medicine is pretty bad. Now part of that, perhaps, is that the goalposts keep moving back as we get more and more data on #SGLT2i and #GLP1-RAs. Perhaps prescribers feel overwhelmed? pic.twitter.com/gR7BVi0zCa
— cardio-met (@cardiomet_CE) August 11, 2021
18) . . . that slows uptake of novel therapy, even when we see what our colleagues are doing! We need a more collaborative approach: we need a comprehensive care model. pic.twitter.com/JD4wsjGW1S
— cardio-met (@cardiomet_CE) August 11, 2021
20) Answer the poll and come back to us tomorrow for more discussion and for a link to your CE/#CME ! @DanielJDrucker @mvaduganathan @RenaGosser @stormigale @JasonMordino @CardiacRX @robdeedo @Sglt2inhibitorL @AndreaSikora
— cardio-met (@cardiomet_CE) August 11, 2021
22) Given that the answer to yesterday’s quiz was (a [actually 6.9%]), do you think you could make such a collaborative care model work (or work BETTER) in your shop? Check out the pivotal role of the #cardiometabolic pharmacist: pic.twitter.com/Zyw3Ori6dM
— cardio-met (@cardiomet_CE) August 12, 2021
24) As per excellent work by @co_rtneyRx, pharmacists have been shown to improve patients’ self-care behaviors in DM (Patient Prefer Adherence 2018;12: 2457-2474). By focusing pharmacists’ patient education efforts on sleep, physical activity, and . . .
— cardio-met (@cardiomet_CE) August 12, 2021
24) As per excellent work by @co_rtneyRx, pharmacists have been shown to improve patients’ self-care behaviors in DM (Patient Prefer Adherence 2018;12: 2457-2474). By focusing pharmacists’ patient education efforts on sleep, physical activity, and . . .
— cardio-met (@cardiomet_CE) August 12, 2021
26) In a critically important role, pharmacists can ⬆️ patient access to care and medication regimens. Even evidence-based care isn't effective when patients can't afford them and don't fill the Rx!
— cardio-met (@cardiomet_CE) August 12, 2021
28) Finally, pharmacists can help patients identify appropriate #OTC therapies that are safe for use in cardiometabolic disease (https://t.co/PjyxjuIGZq).
— cardio-met (@cardiomet_CE) August 12, 2021
30) In fact, a home‐based #hypertension control program run by non‐physicians has been shown to provide efficient, effective, and rapid control in a sustainable, adaptable, and scalable model (Clin Cardiol 2019 Feb; 42(2): 285–291).
— cardio-met (@cardiomet_CE) August 12, 2021
32) In summary, despite ongoing public health initiatives, many patients do not receive or follow guideline directed cardiometabolic therapies. Perhaps it’s time to rethink and redesign care models specifically for cardiometabolic disease by . . .
— cardio-met (@cardiomet_CE) August 12, 2021
34) Collaborative practice agreements allow for pharmacist-led management programs. Through such programs, clinical algorithms generate timely, effective, and efficient medication management for cardiometabolic disease . . .
— cardio-met (@cardiomet_CE) August 12, 2021
36) You made it! Free CE/#CME! Now, #pharmacists #physcians #nurses go to https://t.co/UhXPZN6K0C and claim credit! I am @johnfanikos. Follow us for more accredited #tweetorials!
— cardio-met (@cardiomet_CE) August 12, 2021